Emerging in vitro research suggests that lemongrass (Cymbopogon citratus) powder can function as a natural biosorbent for certain mycotoxins, including trichothecenes produced by Fusarium species. Trichothecenes such as T-2 toxin and deoxynivalenol are highly stable and difficult to neutralize once ingested, making intestinal binding an attractive supportive strategy. (1, 2)
Lemongrass powder appears to bind mycotoxins through physical adsorption to its plant fiber matrix, including cellulose, hemicellulose, and lignin. These structural components provide charged and porous surfaces that can sequester mycotoxins and reduce their bioavailability. Several laboratory studies have demonstrated that lemongrass and related plant materials can significantly reduce detectable concentrations of Fusarium mycotoxins when incubated together in solution, supporting its potential role as a dietary binder. (3, 4)
In addition to binding capacity, lemongrass has documented antifungal and antioxidant properties, which may further support detoxification by reducing fungal burden and oxidative stress associated with mycotoxin exposure. While this evidence is primarily from in vitro and food safety models, the findings suggest that lemongrass powder may be a useful adjunct in mycotoxin management protocols, particularly for Fusarium and trichothecene exposure. (5, 6)
Human clinical trials are still lacking, so lemongrass powder should be viewed as a supportive, not standalone, strategy within a broader detoxification and exposure reduction plan.
Disclaimer: This information is provided for educational purposes only and does not constitute medical advice; individuals should not self-diagnose or self-treat based on this content and should always consult their licensed healthcare provider or a board-certified physician before using any supplement or therapy for suspected mycotoxin exposure or related health concerns.
Resources:
